METHYL 3-BROMOISOXAZOLE-5-CARBOXYLATE, 95.0%, 100mg

GOLVATINIB, 95%, 100mg

TARANABANT, 95%, 2mg

4-Methylpyrimidine>96.0%(T)25g

Methyl 3-bromo-2,2-dimethylpropanoate, 95%, 250mg

1,4-Diaminobutane>98.0%(GC)(T)400g

N-(Pyridin-3-yl)methanesulfonamide, 98.0%, 1g

Recipiente de cristalización ROTILABO® sin pico, 100 ml, 70 mm, 10 Unidad(es)

(3-((2-Chlorobenzyl)oxy)phenyl)boronic acid, 98%, 250mg

tert-Butyl (4-methoxyphenyl)carbamate, 95.0%, 25g

Methyl 3-(methylamino)propanoate, 95.0%, 1g

Scandium(III) Trifluoromethanesulfonate>98.0%(T)1g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(tert-butoxy)propanoic acid, 95.0%, 2.5g